Obstructive Airway Diseases Medicine Use

This key economic indicator for the Pharmaceutical sector has been recently updated.

  1. Finland Obstructive Airway Diseases Medicine Use jumped by 1.9% in 2019, compared to the previous year.
  2. Since 2014 Finland Obstructive Airway Diseases Medicine Use jumped by 2.6% year on year at 78.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day.
  3. In 2019 Norway was number 3 in Obstructive Airway Diseases Medicine Use.
  4. In 2019 Portugal was number 19 in Obstructive Airway Diseases Medicine Use with 32.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day, moving from 20 in 2018.

Top Countries in Obstructive Airway Diseases Medicine Use

# 27 Countries Units (Defined Daily Dosage) Per Thousand Persons Per Day Last YoY 5‑years CAGR
1 #1
United Kingdom
96 2019 +1.4 % +0.3 % View data
2 #2
Finland
79 2019 +1.9 % +2.6 % View data
3 #3
Norway
68 2019 +0.8 % +0.9 % View data
4 #4
Netherlands
60 2019 -0.2 % +0.0 % View data
5 #5
Denmark
60 2019 +0.0 % +0.4 % View data
6 #6
Sweden
56 2019 +0.7 % +1.4 % View data
7 #7
Czech Republic
55 2019 +2.0 % +3.3 % View data
8 #8
Belgium
54 2019 +0.7 % +0.9 % View data
9 #9
Spain
52 2019 +1.2 % +2.0 % View data
10 #10
Germany
50 2019 +0.2 % -0.4 % View data
11 #11
Greece
49 2019 +0.0 % -0.7 % View data
12 #12
Iceland
45 2019 +0.4 % +1.9 % View data
13 #13
Slovenia
44 2019 +1.4 % +2.0 % View data
14 #14
Hungary
43 2019 +2.1 % +0.6 % View data
15 #15
Turkey
43 2019 +3.6 % +6.1 % View data
16 #16
Canada
37 2019 +2.8 % +5.4 % View data
17 #17
Slovakia
36 2019 +0.6 % -2.9 % View data
18 #18
Australia
33 2019 -3.0 % -2.5 % View data
19 #19
Portugal
32 2019 +1.9 % -1.1 % View data
20 #20
Italy
32 2019 -0.3 % -4.5 % View data
21 #21
Estonia
28 2019 +0.7 % +3.9 % View data
22 #22
Israel
26 2019 -0.8 % +4.8 % View data
23 #23
Austria
26 2019 +1.2 % +4.6 % View data
24 #24
Lithuania
23 2019 +0.9 % -1.2 % View data
25 #25
Luxembourg
22 2019 +0.0 % -2.6 % View data
26 #26
South Korea
14 2019 +0.0 % -0.1 % View data
27 #27
Latvia
8 2019 +0.0 % -2.0 % View data

Source: OECD

Go Top